Announcements Trials

Browse Landscape

Status

Unknown 1 Recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 13 Esophageal Squamous Cell Carcinoma 7 Carcinoma, Non-Small-Cell Lung 5 Stomach Neoplasms 4 Rectal Neoplasms 4 Neoplasms 4 Uterine Cervical Neoplasms 2 Urinary Bladder Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma 2 Ovarian Neoplasms 2 Nasopharyngeal Carcinoma 2 Lung Neoplasms 2 Head and Neck Neoplasms 2 Esophageal Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Hepatocellular 2 Turcot syndrome 1 Testicular Neoplasms 1 Squamous Cell Carcinoma of External Auditory Canal 1 Seminoma 1 Recurrence 1 Pathologic Complete Response 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Pancreatic Neoplasms 1 Pancreatic Ductal Adenocarcinoma (PDAC) 1 Neoplastic Cells, Circulating 1 Neoplasm Metastasis 1 Neoadjuvant Therapy 1 Muscle Invasive Bladder Cancer 1

Interventions

Blood Specimen Collection 5 Liquid Biopsy 2 Folfox protocol 2 Carboplatin 2 pertuzumab 1 Trastuzumab 1 Surgical Procedures, Operative 1 Standard of Care 1 Sevoflurane 1 Radiotherapy, Adjuvant 1 Propofol 1 Positron Emission Tomography Computed Tomography 1 Paclitaxel 1 Neoadjuvant Therapy 1 Mastectomy, Segmental 1 Gemcitabine 1 Fluorouracil 1 Epirubicin 1 Drug Therapy 1 Docetaxel 1 Cyclophosphamide 1 Colonography, Computed Tomographic 1 Cisplatin 1 Chemotherapy, Adjuvant 1 Capecitabine 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Neoplastic Cells, Circulating × Neoadjuvant Therapy × Clear all

NCT04902937 2023-11-28

CETC

University of Jena

Neoplastic Cells, Circulating

Data powered by HemOnc (CC BY 4.0) Colophon ⚡